ALKBH5 mediates FGF21 m6A demethylation in human bone marrow mesenchymal stem cells under high glucose conditions
- 16 May 2025
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 774, 152042
Abstract
No abstract availableKeywords
This publication has 73 references indexed in Scilit:
- The crucial mechanism and therapeutic implication of RNA methylation in bone pathophysiologyAgeing Research Reviews, 2022
- The clinician’s guide to prevention and treatment of osteoporosisOsteoporosis International, 2022
- Impact of Type 2 Diabetes Mellitus and Antidiabetic Medications on Bone MetabolismCurrent Diabetes Reports, 2020
- Increased Expression of FGF-21 Negatively Affects Bone Homeostasis in Dystrophin/Utrophin Double Knockout MiceJournal of Bone and Mineral Research, 2019
- Diabetes and boneOsteoporosis and Sarcopenia, 2019
- m6A modification of non-coding RNA and the control of mammalian gene expressionBiochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms, 2019
- Diagnosis and management of bone fragility in diabetes: an emerging challengeOsteoporosis International, 2018
- Biochemical characterization of the tomato phosphatidylinositol-specific phospholipase C (PI-PLC) family and its role in plant immunityBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2016
- Fibroblast growth factor-21 restores insulin sensitivity but induces aberrant bone microstructure in obese insulin-resistant ratsJournal of Bone and Mineral Metabolism, 2016
- Interactions between FGF21 and BMP-2 in osteogenesisBiochemical and Biophysical Research Communications, 2013